Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention

Area of Science:

• Cardiology
• Medical Device Technology
• Clinical Trials

Background:

• Sudden cardiac death (SCD) is a significant cause of mortality globally.
• Implantable cardioverter-defibrillators (ICDs) are used to manage life-threatening ventricular arrhythmias.
• Guidelines exist for primary prevention ICDs based on randomized trials.

Purpose of the Study:

• To review major clinical trials on primary prevention ICDs.
• To evaluate the evidence supporting the use and potential overuse of ICDs.
• To discuss patient selection for primary prevention ICDs.

Main Methods:

• Systematic review of randomized controlled trials.
• Analysis of guideline criteria for ICD implantation.
• Evaluation of cost-benefit and morbidity data associated with ICDs.

Main Results:

• Clinical trials have informed guidelines for primary prevention ICDs.
• Many patients within guidelines may not have been represented in trials.
• Potential for ICD overuse and exaggerated cost-benefit analyses exists.

Conclusions:

• Primary prevention ICD guidelines require careful patient selection.
• Evidence supporting ICD use needs to be balanced against potential risks and limitations.
• Further research may be needed to refine patient selection criteria and address trial representation.